Literature DB >> 8537536

Measurement of 129Xe T1 in blood to explore the feasibility of hyperpolarized 129Xe MRI.

M S Albert1, V D Schepkin, T F Budinger.   

Abstract

OBJECTIVE: The major obstacle to the use of 129-xenon (I = 1/2) as a new source of contrast in magnetic resonance is its low sensitivity. The hyperpolarized 129Xe-MRI technique using laser optical pumping of rubidium promises to resolve this problem. The potential of xenon-based MRI for the body tissues other than the lung air spaces depends on the 129Xe polarization lifetime (T1) in the blood at a magnetic field of commonly available clinical MRI systems.
MATERIALS AND METHODS: Xenon with natural abundance of 129Xe (26%) was dissolved in human blood and studied at 36 degrees C in a 2.35 T 40 cm bore MRI spectrometer (27.6 MHz). Zeeman relaxation (T1) of six blood samples was measured by the progressive saturation method for periods of 4-8 h each.
RESULTS: NMR spectra revealed two peaks at 216.0 ppm (A) and 194.0 ppm (B) relative to the xenon gas above the blood volume. Assignment and 129Xe T1 values were 4.5 +/- 1 s for red blood cells (A), 9.6 +/- 2 s for plasma (B) and 11.9 +/- 1.6 s for xenon gas at atmospheric oxygen pressure. Xenon dissolved in distilled water appears at 189.8 ppm and has T1 = 26.3 +/- 1.4 s.
CONCLUSION: These relaxation times, though shorter than expected, are comparable to the transport time of blood, and are long enough to encourage use of hyperpolarized xenon for MRI studies in tissues, in addition to lung.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8537536     DOI: 10.1097/00004728-199511000-00025

Source DB:  PubMed          Journal:  J Comput Assist Tomogr        ISSN: 0363-8715            Impact factor:   1.826


  15 in total

1.  Evidence of nonspecific surface interactions between laser-polarized xenon and myoglobin in solution.

Authors:  S M Rubin; M M Spence; B M Goodson; D E Wemmer; A Pines
Journal:  Proc Natl Acad Sci U S A       Date:  2000-08-15       Impact factor: 11.205

2.  Establishing an accurate gas phase reference frequency to quantify 129 Xe chemical shifts in vivo.

Authors:  Rohan S Virgincar; Scott H Robertson; John Nouls; Simone Degan; Geoffry M Schrank; Mu He; Bastiaan Driehuys
Journal:  Magn Reson Med       Date:  2016-04-05       Impact factor: 4.668

3.  In vivo NMR and MRI using injection delivery of laser-polarized xenon.

Authors:  B M Goodson; Y Song; R E Taylor; V D Schepkin; K M Brennan; G C Chingas; T F Budinger; G Navon; A Pines
Journal:  Proc Natl Acad Sci U S A       Date:  1997-12-23       Impact factor: 11.205

4.  NMR of laser-polarized xenon in human blood.

Authors:  A Bifone; Y Q Song; R Seydoux; R E Taylor; B M Goodson; T Pietrass; T F Budinger; G Navon; A Pines
Journal:  Proc Natl Acad Sci U S A       Date:  1996-11-12       Impact factor: 11.205

5.  XeNA: an automated 'open-source' (129)Xe hyperpolarizer for clinical use.

Authors:  Panayiotis Nikolaou; Aaron M Coffey; Laura L Walkup; Brogan M Gust; Nicholas Whiting; Hayley Newton; Iga Muradyan; Mikayel Dabaghyan; Kaili Ranta; Gregory D Moroz; Matthew S Rosen; Samuel Patz; Michael J Barlow; Eduard Y Chekmenev; Boyd M Goodson
Journal:  Magn Reson Imaging       Date:  2014-02-10       Impact factor: 2.546

6.  Parahydrogen-Induced Polarization of Diethyl Ether Anesthetic.

Authors:  Nuwandi M Ariyasingha; Baptiste Joalland; Hassan R Younes; Oleg G Salnikov; Nikita V Chukanov; Kirill V Kovtunov; Larisa M Kovtunova; Valerii I Bukhtiyarov; Igor V Koptyug; Juri G Gelovani; Eduard Y Chekmenev
Journal:  Chemistry       Date:  2020-09-17       Impact factor: 5.236

7.  Uncovering a third dissolved-phase 129 Xe resonance in the human lung: Quantifying spectroscopic features in healthy subjects and patients with idiopathic pulmonary fibrosis.

Authors:  Scott H Robertson; Rohan S Virgincar; Elianna A Bier; Mu He; Geoffrey M Schrank; Rose Marie Smigla; Craig Rackley; H Page McAdams; Bastiaan Driehuys
Journal:  Magn Reson Med       Date:  2016-11-08       Impact factor: 4.668

8.  Spin-lattice relaxation of laser-polarized xenon in human blood.

Authors:  J Wolber; A Cherubini; A S Dzik-Jurasz; M O Leach; A Bifone
Journal:  Proc Natl Acad Sci U S A       Date:  1999-03-30       Impact factor: 11.205

9.  Imaging techniques for small animal models of pulmonary disease: MR microscopy.

Authors:  Bastiaan Driehuys; Laurence W Hedlund
Journal:  Toxicol Pathol       Date:  2007-01       Impact factor: 1.902

10.  Low-Flammable Parahydrogen-Polarized MRI Contrast Agents.

Authors:  Baptiste Joalland; Nuwandi M Ariyasingha; Hassan R Younes; Shiraz Nantogma; Oleg G Salnikov; Nikita V Chukanov; Kirill V Kovtunov; Igor V Koptyug; Juri G Gelovani; Eduard Y Chekmenev
Journal:  Chemistry       Date:  2021-01-07       Impact factor: 5.236

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.